Top Stories America
Search
Categories

Archive for the ‘START’ Category

South Texas Accelerated Research Therapeutics (START) has enrolled its first patient in a phase 1 clinical trial of a combination anticancer regimen made up of two investigational compounds.

Atlanta Boston Charlotte Chicago Cincinnati Cleveland Columbus Dallas Denver Detroit